Abstract
Infections of the central nervous system among immunocompromised patients are of major clinical relevance due to the high morbidity and mortality they convey.
The clinical approach to central nervous system (CNS) infections is based on keeping a low threshold of suspicion and recognizing the classic clinical syndromes together with the particularities that occur in immunocompromised patients: subacute onset, subtle and overlapped clinical presentation, and the presence of opportunistic agents in addition to traditional pathogens and sometimes the presence of more than one infectious agent.
The etiologic study should be oriented according to the clinical presentation syndrome and the underlying immunodepression model. Imaging studies should always be performed, and the cerebrospinal fluid should be analyzed. Finally, and particularly in the case of brain lesions with mass effect, early tissue collection should be considered.
The treatment has to be directed to agents related to the clinical syndrome and the underlying immune defect model identified. The timely initiation of empirical antimicrobials is warranted, and it should include broad-spectrum antimicrobials with adequate penetration to the central nervous system. Finally, the availability of adjunctive therapies to antimicrobials that may have additional utility in particular cases (e.g., corticoids in the case of pneumococcal meningitis) should be taken into account.
This is a preview of subscription content, log in via an institution to check access.
References
Armstrong R, Fung P. Brainstem encephalitis (Rhombencephalitis) due to Listeria monocytogenes: case report and review. Clin Infect Dis. 1993;16:689–702. https://doi.org/10.1093/clind/16.5.689.
Balaguer Rosello A, Bataller L, Lorenzo L, et al. Infections of the central nervous system after unrelated donor umbilical cord blood transplantation or human leukocyte antigen–matched sibling transplantation. Biol Blood Marrow Transplant. 2017;23:134–9. https://doi.org/10.1016/j.bbmt.2016.10.005.
Cunha B. Central nervous system infections in the compromised host: a diagnostic approach. Infect Dis Clin N Am. 2001;15:567–90. https://doi.org/10.1016/s0891-5520(05)70160-4.
Denkinger C, Schumacher S, Boehme C, et al. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2014;44:435–46. https://doi.org/10.1183/09031936.00007814.
Hanajiri R, Kobayashi T, Yoshioka K, et al. Central nervous system infection following allogeneic hematopoietic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2017;10:22–8. https://doi.org/10.1016/j.hemonc.2016.08.008.
Pappas P, Chetchotisakd P, Larsen R, et al. A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis. 2009;48:1775–83. https://doi.org/10.1086/599112.
Patterson T, Thompson G, Denning D, et al. Executive summary: practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:433–42. https://doi.org/10.1093/cid/ciw444.
Schmidt-Hieber M, Silling G, Schalk E, et al. CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation) – guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2016;27:1207–25. https://doi.org/10.1093/annonc/mdw155.
Schwartz S, Kontoyiannis D, Harrison T, Ruhnke M. Advances in the diagnosis and treatment of fungal infections of the CNS. Lancet Neurol. 2018;17:362–72. https://doi.org/10.1016/s1474-4422(18)30030-9.
Sonneville R, Magalhaes E, Meyfroidt G. Central nervous system infections in immunocompromised patients. Curr Opin Crit Care. 2017;23:128–33. https://doi.org/10.1097/mcc.0000000000000397.
Tanner D, Weinstein M, Fedorciw B, et al. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol. 1994;32:1680–4.
Tunkel A, Hartman B, Kaplan S, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267–84. https://doi.org/10.1086/425368.
van Veen K, Brouwer M, van der Ende A, van de Beek D. Bacterial meningitis in hematopoietic stem cell transplant recipients: a population-based prospective study. Bone Marrow Transplant. 2016;51:1490–5. https://doi.org/10.1038/bmt.2016.181.
Wheat J, Myint T, Guo Y, et al. Central nervous system histoplasmosis: multicenter retrospective study on clinical features, diagnostic approach and outcome of treatment. Medicine. 2018;97:e0245. https://doi.org/10.1097/md.0000000000010245.
Wu M, Huang F, Jiang X, et al. Herpesvirus-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation. PLoS One. 2013;8:e77805. https://doi.org/10.1371/journal.pone.0077805.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Araos, R., Aldana, G. (2019). Frequent Central Nervous System (CNS) Infections in the Immunosuppressed Patient. In: Nates, J., Price, K. (eds) Oncologic Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-74698-2_39-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-74698-2_39-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74698-2
Online ISBN: 978-3-319-74698-2
eBook Packages: Springer Reference MedicineReference Module Medicine